Merck & Co., Inc. Cost of Revenue 2007-2026 | MRK
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is Merck & Co., Inc.'s current cost of revenue?
Merck & Co., Inc. (MRK) annual cost of revenue for 2025 was $16.38B, a 7.83% increase from 2024. Merck & Co., Inc. cost of revenue for the quarter ending March 31, 2026 was $4.20B.
What was Merck & Co., Inc.'s cost of revenue in 2024?
Merck & Co., Inc. annual cost of revenue for 2024 was $15.19B, a 5.79% decline from 2023.
What was Merck & Co., Inc.'s cost of revenue in 2023?
Merck & Co., Inc. annual cost of revenue for 2023 was $16.13B, a 7.38% decline from 2022.
What is Merck & Co., Inc.'s 5-year cost of revenue CAGR?
Merck & Co., Inc. cost of revenue grew at a compound annual growth rate (CAGR) of 3.76% from FY2020 to FY2025, going from $13.62B to $16.38B over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+3.8%
FY2020
$13.62B
→
FY2025
$16.38B
07080910111213141516171819202122232425
5 years selected
Cost of Revenue History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $16.38B | +7.8% | 10-K |
| FY2024 | $15.19B | -5.8% | 10-K |
| FY2023 | $16.13B | -7.4% | 10-K |
| FY2022 | $17.41B | +27.8% | 10-K |
| FY2021 | $13.63B | +0.1% | 10-K |
| FY2020 | $13.62B | +13.3% | 10-K |
| FY2019 | $12.02B | -11.1% | 10-K |
| FY2018 | $13.51B | +5.7% | 10-K |
| FY2017 | $12.78B | -8.0% | 10-K |
| FY2016 | $13.89B | -7.0% | 10-K |
| FY2015 | $14.93B | -10.9% | 10-K |
| FY2014 | $16.77B | -1.1% | 10-K |
| FY2013 | $16.95B | +3.1% | 10-K |
| FY2012 | $16.45B | -2.5% | 10-K |
| FY2011 | $16.87B | -8.3% | 10-K |
| FY2010 | $18.40B | +104.0% | 10-K |
| FY2009 | $9.02B | +61.5% | 10-K |
| FY2008 | $5.58B | -9.1% | 10-K |
| FY2007 | $6.14B | - | 10-K |
Company: Merck & Co., Inc.Ticker: MRKSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →